Tumor cells were reactive to SMA, cluster of differentiation 34 (CD34) (focally), transducin-like enhancer of split-1 (TLE-1) (focally), and cyclin D1, with nuclear staining of beta-catenin, while it was not reactive to cytokeratins. Here, TLE1 is linked to neoplasm.